Company

Viracta

Rocket Ship Rating

Rocket Ship Rating: 95 out of 100

Also known as Viracta Therapeutics, Inc.

Biotech & therapeutics

Business model: B2B
Legal name: Viracta Therapeutics, Inc.

viracta.com (opens in a new tab)

Open relationship map

Claim, correct or request removal

Record updated 28 September 2026

About

Viracta Therapeutics, Inc. (“Company”), a precision oncology company formerly based in Cardiff, CA.

Funding snapshot

Total raised: $173MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
Latest round: Round, $65M2021-02-24

Funding rounds

Round, 2021: $65M2021-02-24, SEC form D sold, 26 investors
Round, 2020: $40M2020-11-25, SEC form D sold, 14 investors
Round, 2019: $16.8M2019-10-24, SEC form D sold, 21 investors
Round, 2019: $5.7M2019-01-31, SEC form D sold, 25 investors
Round, 2018: $10.7M2018-11-30, SEC form D sold, 6 investors
Round, 2018: $2.7M2018-06-18, SEC form D sold, 27 investors
Round, 2017: $9.9M2017-03-23, SEC form D sold, 9 investors
Round, 2012: $6.5M2012-03-07, SEC form D sold, 10 investors
Round, 2010: $16.1M2010-01-19, SEC form D sold, 12 investors